SCHEMBL5376964

SCHEMBL5376964

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccc(F)cc3Cl)cc2)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
ALDH1A1 P00352 5/20 0.43
LMNA P02545 3/20 0.43
GAA P10253 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 6/20 0.42
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
MIF P14174 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK1 P28482 1/20 0.39
PABPC1 P11940 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GPR27 Q9NS67 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5378677 0.91 POLB (0.52) POLBALDH1A1LMNASMN1; SMN2HTT
SCHEMBL14434486 0.88 CXCR2 (0.45) POLBALDH1A1LMNAGAAL3MBTL1
SCHEMBL5373887 0.86 POLB (0.49) POLBALDH1A1LMNAGAASMN1; SMN2
SCHEMBL5380728 0.84 MMP13 (0.56) POLBALDH1A1LMNAGAAL3MBTL1
SCHEMBL5376596 0.84 POLB (0.49) POLBALDH1A1LMNAGAAL3MBTL1
SCHEMBL5376499 0.83 POLB (0.46) POLBALDH1A1LMNAGAASMN1; SMN2
SCHEMBL5380795 0.80 POLB (0.47) POLBALDH1A1LMNAGAASMN1; SMN2
SCHEMBL5376768 0.80 GPR27 (0.44) POLBALDH1A1LMNAGAASMN1; SMN2
SCHEMBL5380272 0.80 POLB (0.45) POLBALDH1A1GAASMN1; SMN2MAPT
SCHEMBL5376629 0.80 CASP6 (0.52) POLBALDH1A1LMNAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885ALDH1A1 2956/4885LMNA 319/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885ALDH1A1 2752/4885LMNA 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.